Titre : Cellules spumeuses

Cellules spumeuses : Questions médicales fréquentes

Termes MeSH sélectionnés :

Learning Disabilities
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Cellules spumeuses : Questions médicales les plus fréquentes", "headline": "Cellules spumeuses : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Cellules spumeuses : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-24", "dateModified": "2025-04-18", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Cellules spumeuses" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Macrophages", "url": "https://questionsmedicales.fr/mesh/D008264", "about": { "@type": "MedicalCondition", "name": "Macrophages", "code": { "@type": "MedicalCode", "code": "D008264", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.680.397" } } }, "about": { "@type": "MedicalCondition", "name": "Cellules spumeuses", "alternateName": "Foam Cells", "code": { "@type": "MedicalCode", "code": "D005487", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Maria Kurańska", "url": "https://questionsmedicales.fr/author/Maria%20Kura%C5%84ska", "affiliation": { "@type": "Organization", "name": "Department of Chemistry and Technology of Polymers, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Cracow, Poland." } }, { "@type": "Person", "name": "Aleksander Prociak", "url": "https://questionsmedicales.fr/author/Aleksander%20Prociak", "affiliation": { "@type": "Organization", "name": "Department of Chemistry and Technology of Polymers, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Cracow, Poland." } }, { "@type": "Person", "name": "Aniket Raje", "url": "https://questionsmedicales.fr/author/Aniket%20Raje", "affiliation": { "@type": "Organization", "name": "Institute of Membrane Research, Helmholtz-Zentrum Hereon, Max-Planck-Strasse 1, 21502 Geesthacht, Germany." } }, { "@type": "Person", "name": "Joachim Koll", "url": "https://questionsmedicales.fr/author/Joachim%20Koll", "affiliation": { "@type": "Organization", "name": "Institute of Membrane Research, Helmholtz-Zentrum Hereon, Max-Planck-Strasse 1, 21502 Geesthacht, Germany." } }, { "@type": "Person", "name": "Jelena Lillepärg", "url": "https://questionsmedicales.fr/author/Jelena%20Lillep%C3%A4rg", "affiliation": { "@type": "Organization", "name": "Institute of Membrane Research, Helmholtz-Zentrum Hereon, Max-Planck-Strasse 1, 21502 Geesthacht, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Speech/Language Impairment or Specific Learning Disability? Examining the Usage of Educational Categories.", "datePublished": "2023-01-27", "url": "https://questionsmedicales.fr/article/36706457", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1044/2022_JSLHR-21-00636" } }, { "@type": "ScholarlyArticle", "name": "An investigation into the factor structure of the Health of the Nation Outcome Scales for People with Learning Disabilities.", "datePublished": "2023-08-02", "url": "https://questionsmedicales.fr/article/37530203", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jir.13070" } }, { "@type": "ScholarlyArticle", "name": "The impact of COVID-19 on residents of long-term care facilities with learning disabilities and/or autism.", "datePublished": "2023-04-26", "url": "https://questionsmedicales.fr/article/37123814", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/irv.13139" } }, { "@type": "ScholarlyArticle", "name": "Maternal age at childbirth and the risk of attention-deficit/hyperactivity disorder and learning disability in offspring.", "datePublished": "2023-02-02", "url": "https://questionsmedicales.fr/article/36817892", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2023.923133" } }, { "@type": "ScholarlyArticle", "name": "Review and update of the Health of the Nation Outcome Scales for People with Learning Disabilities (HoNOS-LD).", "datePublished": "2023-05-17", "url": "https://questionsmedicales.fr/article/37198876", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/00207640231175773" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Systèmes sanguin et immunitaire", "item": "https://questionsmedicales.fr/mesh/D006424" }, { "@type": "ListItem", "position": 3, "name": "Système immunitaire", "item": "https://questionsmedicales.fr/mesh/D007107" }, { "@type": "ListItem", "position": 4, "name": "Phagocytes", "item": "https://questionsmedicales.fr/mesh/D010586" }, { "@type": "ListItem", "position": 5, "name": "Macrophages", "item": "https://questionsmedicales.fr/mesh/D008264" }, { "@type": "ListItem", "position": 6, "name": "Cellules spumeuses", "item": "https://questionsmedicales.fr/mesh/D005487" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Cellules spumeuses - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Cellules spumeuses", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Cellules spumeuses", "description": "Comment diagnostique-t-on les cellules spumeuses ?\nQuels tests sont utilisés pour détecter les cellules spumeuses ?\nLes cellules spumeuses sont-elles visibles à l'échographie ?\nQuel rôle joue la biopsie dans le diagnostic ?\nPeut-on détecter les cellules spumeuses par analyse sanguine ?", "url": "https://questionsmedicales.fr/mesh/D005487?mesh_terms=Learning+Disabilities&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Cellules spumeuses", "description": "Quels symptômes sont associés aux cellules spumeuses ?\nLes cellules spumeuses causent-elles des douleurs ?\nComment les cellules spumeuses affectent-elles la circulation ?\nY a-t-il des signes cliniques visibles ?\nLes cellules spumeuses sont-elles liées à des maladies spécifiques ?", "url": "https://questionsmedicales.fr/mesh/D005487?mesh_terms=Learning+Disabilities&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Cellules spumeuses", "description": "Comment prévenir la formation de cellules spumeuses ?\nLe tabagisme influence-t-il les cellules spumeuses ?\nLe stress a-t-il un impact sur les cellules spumeuses ?\nUne alimentation riche en graisses est-elle risquée ?\nL'exercice régulier aide-t-il à prévenir les cellules spumeuses ?", "url": "https://questionsmedicales.fr/mesh/D005487?mesh_terms=Learning+Disabilities&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Cellules spumeuses", "description": "Quels traitements ciblent les cellules spumeuses ?\nLes statines aident-elles contre les cellules spumeuses ?\nY a-t-il des traitements non médicamenteux ?\nLes interventions chirurgicales sont-elles nécessaires ?\nLes traitements naturels sont-ils efficaces ?", "url": "https://questionsmedicales.fr/mesh/D005487?mesh_terms=Learning+Disabilities&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Cellules spumeuses", "description": "Quelles complications sont liées aux cellules spumeuses ?\nLes cellules spumeuses augmentent-elles le risque d'AVC ?\nPeuvent-elles causer des douleurs thoraciques ?\nLes cellules spumeuses sont-elles réversibles ?\nY a-t-il des risques de rupture de plaque ?", "url": "https://questionsmedicales.fr/mesh/D005487?mesh_terms=Learning+Disabilities&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Cellules spumeuses", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il la formation de cellules spumeuses ?\nLe cholestérol élevé est-il un facteur de risque ?\nLe diabète affecte-t-il la santé vasculaire ?\nLe manque d'exercice est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D005487?mesh_terms=Learning+Disabilities&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on les cellules spumeuses ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'analyse histologique des tissus vasculaires." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les cellules spumeuses ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des biopsies et des examens d'imagerie comme l'IRM peuvent être utilisés." } }, { "@type": "Question", "name": "Les cellules spumeuses sont-elles visibles à l'échographie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Elles ne sont généralement pas visibles à l'échographie standard." } }, { "@type": "Question", "name": "Quel rôle joue la biopsie dans le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "La biopsie permet d'observer la présence de cellules spumeuses dans les plaques." } }, { "@type": "Question", "name": "Peut-on détecter les cellules spumeuses par analyse sanguine ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Non, elles sont principalement détectées dans les tissus, pas dans le sang." } }, { "@type": "Question", "name": "Quels symptômes sont associés aux cellules spumeuses ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les cellules spumeuses elles-mêmes ne provoquent pas de symptômes directs." } }, { "@type": "Question", "name": "Les cellules spumeuses causent-elles des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elles ne causent pas de douleurs, mais contribuent à des maladies cardiovasculaires." } }, { "@type": "Question", "name": "Comment les cellules spumeuses affectent-elles la circulation ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent obstruer les vaisseaux sanguins, entraînant des problèmes circulatoires." } }, { "@type": "Question", "name": "Y a-t-il des signes cliniques visibles ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Non, les cellules spumeuses ne présentent pas de signes cliniques visibles." } }, { "@type": "Question", "name": "Les cellules spumeuses sont-elles liées à des maladies spécifiques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont souvent associées à l'athérosclérose et aux maladies cardiaques." } }, { "@type": "Question", "name": "Comment prévenir la formation de cellules spumeuses ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir un mode de vie sain avec une alimentation équilibrée et de l'exercice." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il les cellules spumeuses ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente le risque de formation de cellules spumeuses et d'athérosclérose." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur les cellules spumeuses ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Le stress chronique peut contribuer à des maladies cardiovasculaires, y compris les cellules spumeuses." } }, { "@type": "Question", "name": "Une alimentation riche en graisses est-elle risquée ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en graisses saturées favorise la formation de cellules spumeuses." } }, { "@type": "Question", "name": "L'exercice régulier aide-t-il à prévenir les cellules spumeuses ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier améliore la santé cardiovasculaire et réduit les risques." } }, { "@type": "Question", "name": "Quels traitements ciblent les cellules spumeuses ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements visent à réduire le cholestérol et à prévenir l'athérosclérose." } }, { "@type": "Question", "name": "Les statines aident-elles contre les cellules spumeuses ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les statines réduisent le cholestérol et limitent la formation de cellules spumeuses." } }, { "@type": "Question", "name": "Y a-t-il des traitements non médicamenteux ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation saine et l'exercice physique peuvent aider à prévenir leur formation." } }, { "@type": "Question", "name": "Les interventions chirurgicales sont-elles nécessaires ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent être nécessaires en cas de complications graves, comme une occlusion." } }, { "@type": "Question", "name": "Les traitements naturels sont-ils efficaces ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Certains compléments peuvent aider, mais leur efficacité n'est pas prouvée scientifiquement." } }, { "@type": "Question", "name": "Quelles complications sont liées aux cellules spumeuses ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent entraîner des maladies cardiovasculaires graves, comme l'infarctus." } }, { "@type": "Question", "name": "Les cellules spumeuses augmentent-elles le risque d'AVC ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent contribuer à l'athérosclérose, augmentant le risque d'AVC." } }, { "@type": "Question", "name": "Peuvent-elles causer des douleurs thoraciques ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Indirectement, en provoquant des maladies cardiaques qui peuvent entraîner des douleurs." } }, { "@type": "Question", "name": "Les cellules spumeuses sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Une fois formées, elles ne sont pas réversibles, mais leur progression peut être contrôlée." } }, { "@type": "Question", "name": "Y a-t-il des risques de rupture de plaque ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les cellules spumeuses peuvent contribuer à la rupture de plaques athéroscléreuses." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent le tabagisme, l'hypertension, le diabète et l'obésité." } }, { "@type": "Question", "name": "L'âge influence-t-il la formation de cellules spumeuses ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque augmente avec l'âge en raison de l'accumulation de lipides." } }, { "@type": "Question", "name": "Le cholestérol élevé est-il un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un taux de cholestérol élevé favorise la formation de cellules spumeuses." } }, { "@type": "Question", "name": "Le diabète affecte-t-il la santé vasculaire ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diabète augmente le risque de maladies cardiovasculaires et de cellules spumeuses." } }, { "@type": "Question", "name": "Le manque d'exercice est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire augmente le risque de formation de cellules spumeuses." } } ] } ] }

Sources (10000 au total)

Speech/Language Impairment or Specific Learning Disability? Examining the Usage of Educational Categories.

Developmental language disorder (DLD) is a lifelong condition that when impacting educational performance is identified and serviced through U.S. schools as outlined in the Individuals with Disabiliti... We analyzed publicly available data released by the U.S. Department of Education from six school years between 2010 and 2020. We examined the use of S/LI and SLD categories across students of differen... We present a trend in which younger students tend to be identified with the S/LI category, whereas older students tend to be identified with the SLD category. This trend is evident in all 6 years of d... We discuss these findings in the context of research on language disorders to explain this trend. We highlight the potential damaging effects of using inconsistent terminology, including affecting the...

An investigation into the factor structure of the Health of the Nation Outcome Scales for People with Learning Disabilities.

The Health of the Nation Outcome Scales for People with Learning Disabilities (HoNOS-LD) is one of the most used outcome measures in learning disability services in the United Kingdom. There is relati... A data set of HoNOS-LD scales from 571 people with learning disabilities was randomly split into two halves. Exploratory Mokken analysis was applied to the first dataset, and confirmatory scale factor... Two-factor and three-factor solutions were explored in the Mokken analysis, with the three-factor option having somewhat better characteristics. One-factor, three-factor and seven-factor solutions wer... The HoNOS-LD is best conceptualised as consisting of three scales, accounting for 14 items that can be labelled as 'Cognitive and Physical Functioning', 'Behaviour and Mood Disturbances' and 'Function...

The impact of COVID-19 on residents of long-term care facilities with learning disabilities and/or autism.

The COVID-19 pandemic has had disproportionate impact on vulnerable populations including those with learning disabilities. Assessing the incidence and risk of death in such settings can improve the p... Surveillance records for COVID-19 infections in England from 02 February 2020 to 31 March 2022 were extracted. Data on property type, variant wave, vaccination, hospitalisation and death were derived ... A total of 3501 individuals were identified as diagnosed with SARS-CoV-2 whilst living in 632 care home properties for learning disabilities and/or autism. Of the 3686 episodes of infection, 80.4% wer... Care home residents with learning disabilities and/or autism have a greater risk of death from COVID-19. Optimising guidance to meet their needs is of great importance....

Maternal age at childbirth and the risk of attention-deficit/hyperactivity disorder and learning disability in offspring.

Studies have shown that young maternal age at childbirth can increase the risk of attention-deficit/hyperactivity disorder (ADHD) in offspring, but a study of the U.S. population has not been reported... This study evaluated the association between young and advanced maternal age at childbirth and offspring risk of ADHD and LD in the U.S. population. Using data from 8,098 participants included in the ... Among all participants, the offspring of subjects with a maternal age at childbirth of 18-24 years had an increased risk of ADHD (OR = 1.34, 95% CI: 1.01, 1.79) and LD (OR = 1.36, 95% CI: 1.06, 1.79) ... These results provide epidemiological evidence showing that young and advanced maternal age at childbirth are associated with ADHD and LD risk....

Review and update of the Health of the Nation Outcome Scales for People with Learning Disabilities (HoNOS-LD).

The Health of the Nation Outcomes Scales for people with Learning Disabilities (HoNOS-LD) is an 18-item measure which provides a structured and standardized approach to rating various clinical and psy... To revise and improve the HoNOS-LD's utility in contemporary intellectual disability (ID) services whilst retaining its original objectives and five-point severity ratings.... ID clinicians were invited to complete an online survey, rating each item on the existing measure for being fit for purpose, identifying issues and suggesting improvements based on their experience of... A total of 75 individuals replied. Respondents had used HoNOS-LD for an average of 8.0 years (... The changes outlined in this paper are based on the advisory group's expert consensus. These changes are intended to improve reliability and validity but now need empirical testing as well as review b...

Approaches used to prevent and reduce the use of restrictive practices on adults with learning disabilities: Protocol for a realist review.

The use of restrictive practices has significant adverse effects on the individual, care providers and organisations. This review will describe how, why, for whom, and in what circumstances approaches... Evidence from the literature will be synthesised using a realist review approach - an interpretative, theory-driven approach to understand how complex healthcare approaches work in reducing the use of... Findings will be used to provide recommendations for practice and policymaking.... In accordance with the guidelines, this realist review protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO) on 4th December 2019 (CRD42019158432)....

Dissociative Trait as a Mediator of Problematic Internet Use in Children with attention-deficit/hyperactivity Disorder and Learning Disabilities.

This study used data from a national birth cohort study to investigate the duration of internet use at the age of 12 years among children diagnosed with attention-deficit/hyperactivity disorder (ADHD)... The 5.5- and 12-year-old Taiwan Birth Cohort Study dataset was used (N = 17,694).... More boys were diagnosed with LDs, IDs, ADHD and ASD; however, girls were at increased likelihood of PIU. ID and ASD diagnoses were not associated with increasing PIU likelihood. However, children who... Dissociative absorption was found to be a mediating factor between childhood diagnosis and PIU and can be used as a screening indicator in prevention programs to reduce the duration and severity of PI...

Attention-Deficit Hyperactivity Disorder and Learning Disabilities Modify Recovery and Sport Behavior Following Sport-Related Concussion.

Limited evidence exists concerning how a diagnosis of attention-deficit hyperactivity disorder and/or learning disabilities (ADHD/LD) modifies recovery and behavior following sport-related concussion ...